Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	1128.31	-665.30	54.16
Graham Fair Price	3.89	18.53	17.84
PEG	232.63	1.21	-0.36
Price/Book	-0.77	1.02	1.02
Price/Cash Flow	-1698.05	-573.83	-31.91
Prices/Earnings	-3.25	6.71	6.94
Price/Sales	-5.66	24.34	25.80
Price/FCF	-1698.05	-573.83	-31.91
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	147.55	1.42	0.57
Operating Margin	4.36	0.99	0.95
ROA	6.67	0.02	0.02
ROE	0.04	0.04	2.57
ROIC	0.02	0.02	14.64
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.02	0.03	-49.13
Dividends QOQ	0.02	< 0.005	-63.14
EBIT QOQ	0.45	0.16	-63.27
EPS QOQ	-0.19	0.06	-70.92
FCF QOQ	-8.80	0.94	-89.31
Revenue QOQ	-0.16	0.11	-27.80
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	390.79	0.44	-99.89
Days Sales Outstanding (DSO)	52.91	84.36	59.46
Inventory Turnover	0.23	206.00	89347.37
Debt/Capitalization	0.52	0.50	-3.56
Quick Ratio	2.13	1.70	-20.21
Naive Interpretation	member

04 - Leverage & Liquidity · Balanced

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	19.58	20.09	2.58
Cash	0.94	0.86	-7.74
Capex	0.00	0.00	0.00
Free Cash Flow	-0.63	-0.04	94.34
Revenue	0.78	0.84	7.90
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	2.13	1.82	-14.72
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	27.01	-321.00	1088.26
Naive Interpretation	Member

06 - Financial Health · Weak

Rating